Correlation Between Edesa Biotech and Pulmatrix
Can any of the company-specific risk be diversified away by investing in both Edesa Biotech and Pulmatrix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edesa Biotech and Pulmatrix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edesa Biotech and Pulmatrix, you can compare the effects of market volatilities on Edesa Biotech and Pulmatrix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edesa Biotech with a short position of Pulmatrix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edesa Biotech and Pulmatrix.
Diversification Opportunities for Edesa Biotech and Pulmatrix
-0.78 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Edesa and Pulmatrix is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Edesa Biotech and Pulmatrix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pulmatrix and Edesa Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edesa Biotech are associated (or correlated) with Pulmatrix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pulmatrix has no effect on the direction of Edesa Biotech i.e., Edesa Biotech and Pulmatrix go up and down completely randomly.
Pair Corralation between Edesa Biotech and Pulmatrix
Given the investment horizon of 90 days Edesa Biotech is expected to under-perform the Pulmatrix. In addition to that, Edesa Biotech is 1.15 times more volatile than Pulmatrix. It trades about -0.03 of its total potential returns per unit of risk. Pulmatrix is currently generating about 0.05 per unit of volatility. If you would invest 379.00 in Pulmatrix on November 2, 2024 and sell it today you would earn a total of 388.00 from holding Pulmatrix or generate 102.37% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edesa Biotech vs. Pulmatrix
Performance |
| Timeline |
| Edesa Biotech |
| Pulmatrix |
Edesa Biotech and Pulmatrix Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edesa Biotech and Pulmatrix
The main advantage of trading using opposite Edesa Biotech and Pulmatrix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edesa Biotech position performs unexpectedly, Pulmatrix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pulmatrix will offset losses from the drop in Pulmatrix's long position.| Edesa Biotech vs. SAB Biotherapeutics | Edesa Biotech vs. Senti Biosciences | Edesa Biotech vs. Cingulate | Edesa Biotech vs. Indaptus Therapeutics |
| Pulmatrix vs. Capricor Therapeutics | Pulmatrix vs. Akari Therapeutics PLC | Pulmatrix vs. Soleno Therapeutics | Pulmatrix vs. Bio Path Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |